@EscaygLab

We use mouse models to study neurological disorders such as epilepsy, autism, and AD. We also work on disease gene discovery and treatment development.

Joined December 2021
  • Tweets48
  • Following69
  • Followers110
5Media
We're looking for motivated postdocs that are passionate about studying epilepsy and other neurological disorders! Check out our website and come join us in awesome Atlanta! escayglab.com

Escayg lab | epilepsy and other neurological disorders

Our neurogenetics lab uses a combination of human and mouse genetics, molecular techniques, EEG analysis, behavioral analyses, and genome analysis/bioinformatics to study neurological and neuropsyc...

escayglab.com
3
5
769
Happy holidays from the Escayg lab!
5
82
Escayg Lab retweeted
Escayg Lab@EscaygLab20 Apr 2024
We're looking for motivated postdocs that are passionate about studying epilepsy and other neurological disorders! Check out our website and come join us in awesome Atlanta! escayglab.com

Escayg lab | epilepsy and other neurological disorders

Our neurogenetics lab uses a combination of human and mouse genetics, molecular techniques, EEG analysis, behavioral analyses, and genome analysis/bioinformatics to study neurological and neuropsyc...

escayglab.com
3
5
769
A bit delayed, but congratulations to Dr. Shiu! @thomasShiu1
9
170
We show that lack of full-length ADGRB3 results in reduced brain/body weight ratio and impaired social interaction! Congrats on another 1st author paper, Thomas! @thomasShiu1 onlinelibrary.wiley.com/doi/…

Generation and initial characterization of mice lacking full‐length BAI3 (ADGRB3) expression

Brain-specific angiogenesis inhibitor 3 (ADGRB3/BAI3) belongs to the family of adhesion G protein-coupled receptors. It is most highly expressed in the brain where it plays a role in synaptogenesis...

onlinelibrary.wiley.com
1
1
5
350
Stop by poster 2.335 today to hear about our functional characterization of ATP6V0C! Tomorrow, come by 3.277 to see the latest work on our nanoparticle-encapsulated NPY formulation!
1
1
We're at #AES2022! Let us know if you want to meet up! Come check out the latest work from the Escayg lab: posters 1.059 (BCL11A), 2.335 (ATP6V0C), and 3.277 (nanoparticle-encapsulated NPY)!
Escayg Lab@EscaygLab19 Nov 2022
We are recruiting postdocs for our neurogenetics laboratory! We will be at #AES2022. If you will be in Nashville, please reach out to us and we will be happy to meet. For more information: faculty-emory.icims.com/jobs…
1
2
Hey #neurotwitter! Will you be in #Nashville for #AES2022? Join us (and @TheNotoriousEEG, of course) for a tweet-up! Sunday 12/4, 5:30 - 7:00, Music City Center Rm 211 (conference badge required to attend). #epilepsy
5
7
6
41
We’re headed to #AES2022 tomorrow! Contact us if you’re interested in a postdoc and want to meet at AES! 🤓
Escayg Lab@EscaygLab19 Nov 2022
We are recruiting postdocs for our neurogenetics laboratory! We will be at #AES2022. If you will be in Nashville, please reach out to us and we will be happy to meet. For more information: faculty-emory.icims.com/jobs…
2
5
We are recruiting postdocs for our neurogenetics laboratory! We will be at #AES2022. If you will be in Nashville, please reach out to us and we will be happy to meet. For more information: faculty-emory.icims.com/jobs…
2
2
6
Honored to receive the NIH Director's New Innovator Award @NIH_CommonFund #NIHHighRisk to study advanced stem cell models of the brain! @ColumbiaMed @CSCIColumbia @SCN8AAlliance @curestxbp1 #stemcells #epilepsy Makinsonlab.com commonfund.nih.gov/newinnova…
16
6
5
50
Great job, Thomas! Representing the lab at the DOHG retreat! 🤓
1
7
Congrats to @jemenz01 on this paper! Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach onlinelibrary.wiley.com/doi/… @kswilcox

Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach

Objective Pharmacokinetics (PK) of a drug drive its exposure, efficacy, and tolerability. A thorough preclinical PK assessment of antiseizure medications (ASMs) is therefore essential to evaluate...

onlinelibrary.wiley.com
1
4
Excited to share our latest paper where we report heterozygous variants in ATP6V0C in 27 patients with neurodevelopmental challenges with or without epilepsy. Thank you to all of the coauthors and families! academic.oup.com/brain/advan…

ATP6V0C variants impair V-ATPase function causing a neurodevelopmental disorder often associated...

Mattison et al. identify ATP6V0C variants in patients with a neurodevelopmental syndrome. Using computational modelling and studies in Drosophila, yeast an

academic.oup.com
2
3
16
New gene related to neurodevelopmental disorder + #epilepsy👉 #ATP6V0C In this project leaded by K Mattison & @EscaygLab, we describe the phenotype 🧬 ➡️ early onset Epilepsy ➡️ main seizure: TCS ➡️ wide range of intel disability ➡️ c callosum & cerebellar alt ➡️ cardiopathy
Konrad Platzer
@platzer_k9 Sep 2022
#ATP6V0C is a new AD #MorbidGene for a NDD w/ epilepsy, corpus callosum hypoplasia & cardiac abnormalities. @Brain1878 @ArthurSorlin @FiladelfiaGene1 @TrinebjR @AledoNeuro @smbanka et al. 👌👇 academic.oup.com/brain/advan…

ATP6V0C variants impair V-ATPase function causing a neurodevelopmental disorder often associated...

Mattison et al. identify ATP6V0C variants in patients with a neurodevelopmental syndrome. Using computational modelling and studies in Drosophila, yeast an

academic.oup.com
1
4
1
16
Load more